Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

Intracranial Arterial Diseases Clinical Trial

Official title: Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

Status Recruiting

Clinical Trial Summary

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis.

Clinical Trial Description

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis in two years. Dyslipidemia patients with intracranial arterial stenosis will be enrolled under informed consent in this study. Rosuvastatin (5mg) will be orally administered once daily. Dose of rosuvastatin will be adjusted to control serum LDL-c level under 1.8mmol/L. Primary outcome is the progression of intracranial stenosis on magnetic resonance angiography (MRA) after two years. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Intracranial Arterial Diseases

• NCT number: NCT02341794
• Study type: Interventional
• Source: Tokyo Medical University
• Contact: Hitoshi Aizawa, MD, PhD
• Phone: +813-3342-6111
• Email: haizawa@tokyo-med.ac.jp
• Status: Recruiting
• Phase: N/A
• Start date: January 2015
• Completion date: July 2018